RecruitingPhase 2MDMA

MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder

Sponsored by Stephen Robert Marder

NCT ID
NCT05790239
Target Enrollment
40 participants
Start Date
2025-03-01
Est. Completion
2026-03

About This Study

This randomized, double-blind, single-site phase II 2-arm study will investigate the safety and preliminary efficacy of MDMA-assisted therapy compared with low dose d-amphetamine-assisted therapy on the severity of PTSD symptoms in participants aged 18 years and older with PTSD of at least moderate severity.

Conditions Studied

Post Traumatic Stress Disorder

Interventions

  • 3,4-methylenedioxymethamphetamine
  • d-amphetamine
  • Therapy

Eligibility

Age:18 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* At Screening, meet DSM-5 criteria for current PTSD with a symptom duration of at least 6 months.
* Fluent in speaking and reading the predominantly used or recognized language of the study site (English).
* Must be a veteran enrolled at a VA Healthcare Center in the Greater Los Angeles area.
* Able to swallow pills.
* Agree to have study visits audiovisually recorded, including Experimental Sessions, IR assessments, and non-drug therapy sessions.
* Able to provide a contact (relative, spouse, close friend, or other support person) who is willing and able to be reached by the investigators in the event of the participant becoming unwell or unreachable.
* Able to identify appropriate support person(s) to stay with the participant on the evenings of Experimental Sessions if needed.
* May have well-controlled hypertension that has been successfully treated with anti-hypertensive medicines, if they pass additional screening to rule out underlying cardiovascular disease.
* May have asymptomatic Hepatitis C virus (HCV) that has previously undergone evaluation and treatment as needed.
* Body weight of at least 45 kilograms (kg). Participants with a body weight of 45-48 kg must also have a body mass index (BMI) within the range of 18 to 30 kg/m2. BMI must be within 18 to 32 kg/m2 (inclusive).
* A person able to be pregnant (PABP) must use a highly effective contraceptive method.

Exclusion Criteria:

* Are not able to give adequate informed consent.
* Have evidence or history of significant medical or psychiatric disorders.
* Are abusing illegal drugs.
* Unable or unwilling to safely taper off prohibited psychiatric medication.
* Current enrollment in any other clinical study involving an investigational study treatment or any other type of medical research, unless approved by the study clinician.

Study Locations (2)

VA Greater Los Angeles Healthcare System, Westwood campus
Los Angeles, California, United States
West Los Angeles Veteran Affairs
Los Angeles, California, United States

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

Stephanie L Taylor, PhD
CONTACT
213-505-1140Stephanie.Taylor8@va.gov
Stephen Marder, MD
CONTACT
Stephen.Marder@va.gov
View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source

MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder | Huxley